The China Food and Drug Administration (CFDA) issued an opinion on implementing the Chinese government’s call for increased transparency, expanding public information resources and data collection, increasing training, and strengthening the related supervision and safeguards.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
